Literature DB >> 23174135

Physicians' practice and familiarity with treatment for agitation associated with dementia in Israeli nursing homes.

Jiska Cohen-Mansfield1, Atarah Juravel-Jaffe, Aaron Cohen, Iris Rasooly, Hava Golander.   

Abstract

BACKGROUND: To clarify physicians' actual practice in treating agitation in the nursing home and to elucidate the relationship between background factors, familiarity with interventions, and practice.
METHODS: A survey of actual practice for agitation in persons with dementia was administered to 67 physicians aged 31-70+ working in nursing homes in Israel. Questionnaires were administered by personal interview, self-completed, or a combination of the two.
RESULTS: Psychotropic medications are prescribed by 92.5% of physicians for treating agitation, most notably, Haloperidol (39%). Non-pharmacological treatment was also reported to be common, though to a lesser extent, with environmental change being the most prevalent non-pharmacological intervention. Generally, physicians showed low familiarity levels with non-pharmacological interventions, with higher levels noted for physicians with a specialty in geriatrics compared to those who were non-specialized. Physicians who were non-Israeli and younger also reported higher familiarity levels compared to their respective counterparts (i.e. Israeli and older) but this difference did not reach significance.
CONCLUSION: The findings indicate that, despite current guidelines, psychotropic medications are the treatment of choice among nursing home physicians in Israel. While rates of use of non-pharmacological interventions are substantial, their in-practice application may be hindered by lack of familiarity as well as system barriers. The results have implications for system and education changes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174135     DOI: 10.1017/S104161021200172X

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  9 in total

Review 1.  Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel.

Authors:  Helen C Kales; Laura N Gitlin; Constantine G Lyketsos
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

2.  Advancing Research on Care Needs and Supportive Approaches for Persons With Dementia: Recommendations and Rationale.

Authors:  Ann Kolanowski; Richard H Fortinsky; Margaret Calkins; Davangere P Devanand; Elizabeth Gould; Tamar Heller; Nancy A Hodgson; Helen C Kales; Jeffrey Kaye; Constantine Lyketsos; Barbara Resnick; Melanie Schicker; Sheryl Zimmerman
Journal:  J Am Med Dir Assoc       Date:  2018-08-23       Impact factor: 4.669

3.  Nonpharmacologic treatment of behavioral disorders in dementia.

Authors:  Jiska Cohen-Mansfield
Journal:  Curr Treat Options Neurol       Date:  2013-12       Impact factor: 3.598

Review 4.  Assessment and management of behavioral and psychological symptoms of dementia.

Authors:  Helen C Kales; Laura N Gitlin; Constantine G Lyketsos
Journal:  BMJ       Date:  2015-03-02

Review 5.  Dementia-related agitation: a review of non-pharmacological interventions and analysis of risks and benefits of pharmacotherapy.

Authors:  E O Ijaopo
Journal:  Transl Psychiatry       Date:  2017-10-31       Impact factor: 6.222

6.  Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer's disease: protocol of the BEAT-IT study.

Authors:  Willem S Eikelboom; Ellen Singleton; Esther van den Berg; Michiel Coesmans; Francesco Mattace Raso; Rozemarijn L van Bruchem; Jeannette A Goudzwaard; Frank Jan de Jong; Marc Koopmanschap; Tom den Heijer; Jan J M Driesen; Lilian J H M Vroegindeweij; Elsbeth C Thomeer; Susanne E Hoogers; Anke A Dijkstra; Sytse U Zuidema; Yolande A L Pijnenburg; Philip Scheltens; John C van Swieten; Rik Ossenkoppele; Janne M Papma
Journal:  Alzheimers Res Ther       Date:  2019-05-24       Impact factor: 6.982

7.  Who is informed and who uninformed? Addressing the legal barriers to progress in dementia research and care.

Authors:  Jiska Cohen-Mansfield
Journal:  Isr J Health Policy Res       Date:  2019-02-20

8.  Kaixinsan, a Well-Known Chinese Herbal Prescription, for Alzheimer's Disease and Depression: A Preclinical Systematic Review.

Authors:  Huan Fu; Zhen Xu; Xi-le Zhang; Guo-Qing Zheng
Journal:  Front Neurosci       Date:  2020-01-14       Impact factor: 4.677

9.  The impact of COVID-19 on long-term care facilities and their staff in Israel: Results from a mixed methods study.

Authors:  Jiska Cohen-Mansfield
Journal:  J Nurs Manag       Date:  2022-05-10       Impact factor: 4.680

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.